Pages that link to "Q40633573"

The following pages link to In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines (Q40633573):

Displaying 29 items.

• Studies on anticancer activities of antimicrobial peptides (Q24650885) (← links)
• Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics (Q28548620) (← links)
• The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells (Q33467561) (← links)
• Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315. (Q33624296) (← links)
• Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells (Q33858892) (← links)
• The pH sensitivity of histidine-containing lytic peptides (Q34513192) (← links)
• Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts (Q35683602) (← links)
• Cytotoxic Activity and Antiproliferative Effects of Crude Skin Secretion from Physalaemus nattereri (Anura: Leptodactylidae) on in vitro Melanoma Cells (Q36226841) (← links)
• A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells (Q37040640) (← links)
• From antimicrobial to anticancer peptides. A review (Q37207728) (← links)
• Constructing bioactive peptides with pH-dependent activities (Q37326235) (← links)
• On the physiology and pathophysiology of antimicrobial peptides (Q37327972) (← links)
• Elevation of glutamine level by selenophosphate synthetase 1 knockdown induces megamitochondrial formation in Drosophila cells (Q37432177) (← links)
• Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs (Q37938364) (← links)
• Characterisation of anticancer peptides at the single-cell level. (Q38652902) (← links)
• GL-9 peptide regulates gene expression of CD44 cancer marker and pro-inflammatory cytokine TNF-α in human lung epithelial adenocarcinoma cell line (A549). (Q38733873) (← links)
• Enhanced killing of breast cancer cells by a d-amino acid analog of the winter flounder-derived pleurocidin NRC-03. (Q38837395) (← links)
• Pleurocidin-family cationic antimicrobial peptides mediate lysis of multiple myeloma cells and impair the growth of multiple myeloma xenografts (Q39204624) (← links)
• The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation (Q39214220) (← links)
• Anticancer activity of undecapeptide analogues derived from antimicrobial peptide, brevinin-1EMa (Q39340304) (← links)
• Synthesis of anticancer heptapeptides containing a unique lipophilic β(2,2) -amino acid building block. (Q39411290) (← links)
• Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes (Q39530133) (← links)
• Antitumor and angiostatic peptides from frog skin secretions (Q39623654) (← links)
• Design of NK-2-derived peptides with improved activity against equine sarcoid cells (Q42280878) (← links)
• Mitochondria permeabilization by a novel polycation peptide BTM-P1. (Q44163958) (← links)
• In Silico Design of Anticancer Peptides (Q45065366) (← links)
• Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview (Q45891664) (← links)
• Preparation and properties of silver nanoparticles loaded in activated carbon for biological and environmental applications (Q50436761) (← links)
• Efficient single step chromatographic purification of recombinant human antithrombin (rhAT) from Saccharomyces cerevisiae. (Q54259991) (← links)